What Arlak Biotech does

Arlak Biotech Pvt. Ltd. is a privately held, WHO-GMP certified pharmaceutical marketing and distribution company headquartered in Zirakpur, Punjab, India. The company operates primarily through a PCD (Propaganda Cum Distribution) Pharma Franchise model, recruiting franchise partners and distributors across India who distribute its pharmaceutical formulations under territorial monopoly arrangements. The company markets over 2,500 branded products organized into 16 specialty divisions spanning tablets, capsules, syrups, injectables, ointments, eye drops, dental, dermatology, ayurvedic, pediatric, powder, and sachet dosage forms. Key branded products include PORAZ-20 (omeprazole), MOLD-5 (amlodipine), Fluvetra 20 (fluoxetine), Clariwish 500 (clarithromycin), and the Electrojal electrolyte drink. The company reports its products serve more than 80,000 health professionals across India, supported by 2,000+ franchise associates.

The company's revenue model rests on two streams: (1) PCD pharma franchise sales to franchise partners who receive 30-50% profit margins, annual target incentives, and monthly promotional schemes, and (2) third-party/contract manufacturing services for other pharmaceutical players, covering tablets, capsules, and syrups under custom labeling. Marketing and distribution support is provided to franchisees through visual aids, MR bags, promotional materials, and advertising in leading medical journals (IDR, CIMS, Drug Today). The company holds ISO 9001 and WHO-GMP certifications, with manufacturing in GMP-certified units, and claims to have been conferred the Best Quality Company in Pharma Franchise Award in 2015. Operating geographies are domestic PAN India distribution with emerging export capability signaled through the Arlak International sub-brand and a dedicated export contact channel.

Name

Arlak Biotech

Legal name

Arlak Biotech Pvt. Ltd.

Website

https://arlakbiotech.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Arlak Biotech is a WHO-GMP certified Indian pharmaceutical marketing company operating a PCD franchise model across India. It distributes 2,500+ branded formulations across 16 specialty divisions to 80,000+ health professionals through 2,000+ franchise associates.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing and Distribution

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• PCD pharma franchise
• Pharmaceutical formulations
• Third-party manufacturing
• Pharmaceutical distribution
• Contract manufacturing

Headquarters

HQ city

Kiratpur

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Infrastructure

Revenue model

1. PCD Pharma Franchise: Arlak Biotech operates a PCD (Propaganda Cum Distribution) Pharma Franchise model, recruiting franchise partners across India who distribute their pharmaceutical products. Franchise partners receive profit margins in the range of 30%-50% depending on product range and order volume. The company provides marketing and promotional support to franchisees.
2. Third Party/Contract Manufacturing: Arlak Biotech provides third party manufacturing facility for reputed pharmaceutical players. Services include contract manufacturing of Tablets, Capsules and Syrups, purchasing of raw materials, production, packaging and quality control. The company integrates flexibly into partners' supply chains.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Arlak Biotech is a WHO-GMP certified pharmaceutical marketing company operating a PCD (Propaganda Cum Distribution) pharma franchise model in India. It markets over 2,500 pharmaceutical brands across 16 specialty divisions and also provides third-party/contract manufacturing of tablets, capsules and syrups.

Product overview

Arlak Biotech is a WHO-GMP Certified pharmaceutical marketing and PCD (Propaganda Cum Distribution) pharma franchise company based in India. The company operates as a single unified product portfolio consisting of pharmaceutical formulations across multiple therapeutic categories and dosage forms. Their portfolio includes over 2,500 pharmaceutical brands organized into 16 specialty divisions including RESPILAK (respiratory), NEURATO (neuropsychiatric), and ARLAK KIDS EDITION (pediatric). The product range spans tablets, capsules, injectables, syrups, ointments, eye drops, dental range, derma range, ayurvedic products, powders, sachets, and pediatric drops. Key branded pharmaceutical products include PORAZ-20 (omeprazole), MOLD-5 (amlodipine), Fluvetra 20 (fluoxetine), Clariwish 500 (clarithromycin), Amitriptyline tablets, FEXMO SYRUP (allergy), and Electrojal (electrolyte drink). The company offers these products through PCD pharma franchise business model with marketing and third-party manufacturing services.

Differentiator

Problem solved

Functional benefit

Brands

• RESPILAK: Respiratory products division
• NEURATO – Neuropsychiatric Division
• ARLAK KIDS EDITION
• Soigner
• Astalabs
• Fantabulous Pharma
• Nayan Vision
• Arlak International
• Arlak Ayurveda
• Corazon
• Derma Concepts
• Moruf Lifescience

Products and services

• PCD Pharma Franchise Monopoly-based Propaganda Cum Distribution pharma franchise partnership offering entrepreneurs and pharma professionals across India the right to distribute Arlak's pharmaceutical products in allocated territories, with 30%-50% profit margins and comprehensive marketing support.
• Third Party / Contract Manufacturing Contract manufacturing facility for reputed pharmaceutical companies, covering purchasing of raw materials, production, packaging and quality control of Tablets, Capsules and Syrups with custom labeling solutions.
• Electrojal An electrolyte hydration drink designed for daily summer use, suitable for kids, adults and the elderly, replenishing electrolytes lost through sweating without artificial coloring or excessive sugar.
• PORAZ – 20 Omeprazole 20mg capsule for relief from acidity, heartburn and gastric ulcers.
• MOLD-5 Amlodipine 5mg tablet for management of hypertension and related cardiovascular conditions by relaxing blood vessels and improving blood flow.
• Fluvetra 20 Fluoxetine 20mg tablet used for treating depression, anxiety disorders, panic attacks, OCD, bulimia nervosa and premenstrual dysphoric disorder.
• Clariwish 500 Clarithromycin 500mg tablet, a broad-spectrum antibiotic effective in treating bacterial infections of the respiratory tract and H. pylori.
• Amitriptyline Tablets Amitriptyline tablets (10mg and 25mg) for depression, anxiety disorders, neuropathic pain, migraine prevention and sleep-related conditions.
• FEXMO SYRUP Fexofenadine 30mg + Montelukast 4mg syrup for allergy treatment, packed in 60ml bottles.
• RESPILAK Respiratory care specialty division of Arlak Biotech specializing in respiratory pharma franchise products.
• NEURATO – Neuropsychiatric Division Neuropsychiatric specialty division of Arlak Biotech focusing on psychiatric and neurological medicines.
• ARLAK KIDS EDITION Pediatric product line focused on children's medicines and healthcare products.

Quantifiable outcome

• Profit margins range of 30%-50% for franchise partners
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Pharmaceutical Companies (Unnamed)coreStrategic or Co-development PartnerArlak Biotech provides third party manufacturing facility for reputed pharmaceutical players, offering contract manufacturing of Tablets, Capsules and Syrups with services including purchasing of raw materials, production, packaging and quality control. The company integrates flexibly into partners' supply chain through a mutually beneficial working relationship and strategic alliance.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Centaur Pharmaceuticals: Indian pharma manufacturer/marketer with comparable PCD franchise distribution and contract manufacturing offerings. Similar scale and therapeutic-area breadth make it a close comparable for Arlak.
• Indoco Remedies: Indian branded generics manufacturer with domestic marketing and contract manufacturing arms. Similar mid-tier scale and product portfolio overlap with Arlak's generic-heavy offering.
• Unichem Laboratories: Indian pharma company with branded formulations, active pharmaceutical ingredient manufacturing, and domestic franchise-style distribution. Closely comparable in therapeutic-area breadth and manufacturing-plus-marketing dual focus.
• Macleods Pharmaceuticals: India-headquartered pharma company combining branded generics manufacturing with extensive franchise/contract manufacturing across multiple therapeutic areas. Highly comparable business model to Arlak's PCD franchise plus third-party manufacturing dual-engine approach.

Broad incumbents

• Cipla: Large Indian pharmaceutical incumbent with broad branded generics portfolio including respiratory, neuropsychiatric, and cardiovascular segments that directly overlap Arlak's specialty divisions. Significantly larger but operates the same franchise-and-marketing motion at scale.
• Alkem Laboratories: Mid-to-large Indian pharma company with branded generics, domestic franchise distribution, and contract manufacturing. Larger and more diversified than Arlak, but operates in the same broad pharma franchise and specialty generics space.
• Lupin: Major Indian pharma player with branded generics across cardiology, respiratory, neurology, and other therapeutic areas overlapping Arlak's portfolio. Much larger, but franchise/distribution model and product mix are comparable.
• Zydus Lifesciences: Diversified Indian pharma company with branded generics manufacturing and pan-India marketing presence. While significantly larger, its branded generics portfolio and franchise-style distribution channels overlap directly with Arlak's go-to-market.
• Mankind Pharma: One of India's largest pharma companies with deep franchise-driven distribution and a wide branded generics portfolio. Operates the same PCD-style franchise model at much greater scale and serves the same doctors/chemists channel.

Regional players

• TTK Healthcare: Indian healthcare and pharma company with branded pharma products distributed through franchise and stockist networks. Smaller and more India-focused, making it a comparable regional franchise-led generics competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/arlak_biotech
• Facebookfacebook.com/arlakbiotech
• LinkedInlinkedin.com/company/arlak-biotech

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arlak Biotech